Routine Infectious Diseases Consultations on a Pediatric Cardiac Unit to Improve Positive Blood Culture Management

Costello JM, Graham DA, Morrow DF, Potter-Bynoe G, Sandora TJ, Laussen PC (2009) Risk factors for central line-associated bloodstream infection in a pediatric cardiac intensive care unit. Pediatr Crit Care Med 10(4):453. https://doi.org/10.1097/PCC.0b013e318198b19a

Article  PubMed  Google Scholar 

Pawar M, Mehta Y, Kapoor P, Sharma J, Gupta A, Trehan N (2004) Central venous catheter—related blood stream infections: incidence, risk factors, outcome, and associated pathogens. J Cardiothorac Vasc Anesth 18(3):304–308. https://doi.org/10.1053/j.jvca.2004.03.009

Article  PubMed  Google Scholar 

Mazzeffi M, Gammie J, Taylor B et al (2017) Healthcare-associated infections in cardiac surgery patients with prolonged intensive care unit stay. Ann Thorac Surg 103(4):1165–1170. https://doi.org/10.1016/j.athoracsur.2016.12.041

Article  PubMed  Google Scholar 

Zasowski EJ, Murray KP, Trinh TD et al (2017) Identification of vancomycin exposure-toxicity thresholds in hospitalized patients receiving intravenous vancomycin. Antimicrob Agents Chemother. https://doi.org/10.1128/aac.01684-17.10.1128/aac.01684-17

Article  PubMed  PubMed Central  Google Scholar 

Roger C, Louart B (2021) Beta-lactams toxicity in the intensive care unit: an underestimated collateral damage? Microorganisms 9(7):1505. https://doi.org/10.3390/microorganisms9071505

Article  PubMed  PubMed Central  Google Scholar 

Vardakas KZ, Kalimeris GD, Triarides NA, Falagas ME (2018) An update on adverse drug reactions related to β-lactam antibiotics. Expert Opin Drug Saf 17(5):499–508. https://doi.org/10.1080/14740338.2018.1462334

Article  CAS  PubMed  Google Scholar 

Antibiotic Resistance Threats in the United States. Centers for Disease Control and Prevention, 2019. https://www.cdc.gov/drugresistance/biggest-threats.html Accessed 18 Jan 2024

Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK (2010) The value of infectious diseases consultation in Staphylococcus aureus Bacteremia. Am J Med 123(7):631–637. https://doi.org/10.1016/j.amjmed.2010.01.015

Article  PubMed  PubMed Central  Google Scholar 

Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ (2008) Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus Bacteremia. Clin Infect Dis 46(7):1000–1008. https://doi.org/10.1086/529190

Article  PubMed  Google Scholar 

Jiménez-Aguilar P, López-Cortés LE, Rodríguez-Baño J (2019) Impact of infectious diseases consultation on the outcome of patients with bacteraemia. Ther Adv Infect Dis. https://doi.org/10.1177/2049936119893576

Article  PubMed  PubMed Central  Google Scholar 

Li CN, Jhaveri R (2024) Funding and resourcing quality improvement effort in infectious diseases. Clin Infect Dis Off Publ Infect Dis Soc Am. https://doi.org/10.1093/cid/ciae008

Article  Google Scholar 

Run Chart Rules Reference Sheet. Published online 2019. https://www.ihi.org/sites/default/files/lms/transcriptfiles/education/IHIOpenSchool/Courses/Documents/11_RunChartRulesReferenceSheet.pdf Accessed 20 May 2024

Wolf J, Curtis N, Worth LJ, Flynn PM (2013) Central line–associated bloodstream infection in children: an update on treatment. Pediatr Infect Dis J 32(8):905. https://doi.org/10.1097/INF.0b013e3182996b6e

Article  PubMed  Google Scholar 

Meagher AK, Ambrose PG, Grasela TH, Grosse JE (2005) The pharmacokinetic and pharmacodynamic profile of tigecycline. Clin Infect Dis 41:S333–S340. https://doi.org/10.1086/431674

Article  CAS  PubMed  Google Scholar 

Silverman JA, Mortin LI, VanPraagh ADG, Li T, Alder J (2005) Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 191(12):2149–2152. https://doi.org/10.1086/430352

Article  CAS  PubMed  Google Scholar 

Fishman N, Society for Healthcare Epidemiology of America and Infectious Diseases Society of America (2012) Policy statement on antimicrobial stewardship by the society for healthcare epidemiology of America (SHEA), the infectious diseases society of America (IDSA), and the pediatric infectious diseases society (PIDS). Infect Control Hosp Epidemiol 33(4):322–327. https://doi.org/10.1086/665010

Article  Google Scholar 

Furuichi M, Furuichi M, Horikoshi Y, Miyairi I (2018) Infectious diseases consultation improves treatment and decreases mortality by Enterococcal Bacteremia in children. Pediatr Infect Dis J 37(9):856. https://doi.org/10.1097/INF.0000000000001919

Article  PubMed  Google Scholar 

Duguid RC, Al Reesi M, Bartlett AW, Palasanthiran P, McMullan BJ (2021) Impact of infectious diseases consultation on management and outcome of Staphylococcus aureus Bacteremia in children. J Pediatr Infect Dis Soc 10(5):569–575. https://doi.org/10.1093/jpids/piaa155

Article  CAS  Google Scholar 

Advani SD, Sickbert-Bennett E, Moehring R et al (2023) The disproportionate impact of coronavirus disease 2019 (COVID-19) pandemic on healthcare-associated infections in community hospitals: need for expanding the infectious disease workforce. Clin Infect Dis 76(3):e34–e41. https://doi.org/10.1093/cid/ciac684

Article  PubMed  Google Scholar 

Myers AL, James SH, Watson JR, Yeh S, Bryant KA (2023) Averting a crisis: innovating pediatric infectious diseases recruitment and training. J Pediatr Infect Dis Soc 12(11):559–563. https://doi.org/10.1093/jpids/piad084

Article  Google Scholar 

Reece R, Beckwith CG (2023) The infectious diseases specialist, at risk of extinction. J Infect Dis 228(12):1649–1651. https://doi.org/10.1093/infdis/jiad160

Article  PubMed  Google Scholar 

Kuo D, Gifford DR, Stein MD (1998) Curbside consultation practices and attitudes among primary care physicians and medical subspecialists. JAMA 280(10):905–909. https://doi.org/10.1001/jama.280.10.905

Article  CAS  PubMed  Google Scholar 

Patient Safety Essentials Toolkit | IHI - Institute for Healthcare Improvement. http://www.ihi.org:80/resources/Pages/Tools/Patient-Safety-Essentials-Toolkit.aspx Accessed 22 March 2022

留言 (0)

沒有登入
gif